drug eluting stents – the cell biology andrew newby bristol heart institute ?
TRANSCRIPT
Drug Eluting Stents – The Cell Biology
Andrew Newby BRISTOL HEART
INSTITUTE
?
Basis of neointima formation
ONE WEEK
Thrombus
Inflammation
Injury
Stretch
Early thrombus and later inflammation
% of specimens•Thrombus•Neutrophils•Macrophages•Giant cells
<3 d7279820
Histological findings in 55 coronary in-stent restenosis
specimens Farb et. al. Circulation 1999;95:44-52
4-11 d7883670
12-30 d24729710
>30 d008529
More injury - more restenosis
Serial IVUS - Hoffman et. al. Am J Cardiol 1999;83:1170-4
Smooth muscle cells and extracellular matrix
% of specimensSmooth muscle cellsProteoglycans and HA
<3 d0
4-11 d0
12-30 d45
>30 d100
Farb et. al. Circulation 1999;95:44-52
SMC are 59% of all cells25% of SMC PCNA, cyclinE, and cdk2 positive
Kearney et. al. Circulation 1997;95:1998-2002
Where do neointimal cells come from?
Adventitial fibroblasts?
Medial SMC?
Circulating
stem cells?
Importance of medial injury
Plaque Intact
media
Damaged
media
Intimal thickness (mm)
.2
.4
.6
.8
1
0
Farb et. al. Circulation 1999;95:44-52
Growth factors promote neointima formation (Russell Ross)
m
SMC
SMC
SMC
PDGF
SMC
SMC
SMCSMC
SMC
bFGFIGF-1, TGF
Thrombin, 5HT
PDGF
m
SMC in intact aorta don’t respond to growth factor –FCS induced thymidine incorporation
0.00E+00
2.00E+06
4.00E+06
6.00E+06
0 10 20 30 40 50 hours
DP
M/
g D
NA
isolated cells
aortic tissue
T Izzard et. al. Cardiovasc Res2002: 53; 242-52
Control of smooth muscle cell cycle
G1
S
G2Mitosis
G0Growthfactors
SignalTrans-ductionMAPK
CyclinD/cdk4
DecreasedP16 and p27
ckis
CyclinE/cdk2
R
cdk
cyclinT
Y P
CK
I
p27 levels are maintained and cdk4 kinase activity is inhibited in intact vessels
Intact
Isolated
Intact
Isolated
0 1 2 4 6 8 12 16 24 h0.5
p27 CKI
0 4 8 12 16 24 h
CyclinD/cdk4 activity T Izzard et. al. Cardiovasc Res2002: 53; 242-52
Dual control of smooth muscle cell proliferation
G1
S
G2Mitosis
G0Growthfactors
SignalTrans-ductionMAPK
CyclinD/cdk4
DecreasedP16 and p27
ckis
CyclinE/cdk2
R
Cell Cycle
Matrix protein binding to cell surface integrins
Basis of SMC migration
Matrix proteins
SignalTransduction
Pathways
Activationof CAM-kinase II
Engagementof cell
surfaceintegrins
Cytoskel-etal re-
arrangementChemo-attractant
Migration
Matrix regulation of SMC
Contractile, quiescent SMC
BM, lamininType IV collagen
Fibronectin
Synthetic, migratingproliferating SMC
Fibronectin, osteopontin, vitronectin,Type I, IV, VIII collagen,Versican, hyaluronic acid
Extracellular proteases combine with growth factors to promote neointima
m
SMC
SMC
SMC
MMPs
SMC
SMC
SMCSMC
SMC
MMPs, uPA, other proteases
Migrate
Divide
m
‘Multiple key control’ of the cell cycle
G1
4,5PIP2 – 3,4,5 PIP3G0
PDGF
PI3K
Grb
SOS
raf
PKB mTOR
PLCI1,4,5P3DAG
PKC
ras MEK ERK1/2
PROTEIN KINASES
Steps regulated by mammalian target of rapamycin
G1SMigration!PDGF
PI3K PKB
mTOR
p27 CKI
Matrix proteins
EIF-4EProtein synthesis
p70s6k
Gene expression
Marx and Marks, Circulation 2001;104:852-5. Sun, Circulation 2001;103:2967-72
Inhibition of mTOR by sacrolimus (rapamycin) not tacrolimus
G1SMigration!
mTOR
p27 CKI
EIF-4EProtein synthesis
p70s6k
Gene expression
FKB
FKB
Sirolimus
Tacrolimus
Suzuki et al. Circulation 2001;104:1188-93
ChemokinesMCP-1, IL-6
CN
Microtubules mediate migration and mitosis
Interphase Mitosis
Paclitaxel disrupts the cytoskeleton and inhibits SMC migration and proliferation
Axel et al Circulation 1997; 96:636-45
actin
vimentin
Conclusions –inhibition of SMC proliferation
G1
S
G2Mitosis
G0
Rapamycin -antiproliferative
SignalTrans-ductionMAPK
CyclinD/cdk4
DecreasedP16 and p27
ckis
CyclinE/cdk2
R
Cell Cycle
Matrix proteins
MMPI
Taxol –antimitotic
Conclusions –inhibition of SMC migration
Rapamycin
Decreasedp27
cki
Matrix proteins
MMPI
SignalTransduction
Pathways
Activationof CAM-kinase II
Engagementof cell
surfaceintegrins
Chemo-attractant
Taxol
Cytoskel-etal rear-
rangement
RapamycinThe jury considers the evidence